Paradigm Biopharmaceuticals recently announced the quotation of over 11 million new ordinary fully paid securities on the Australian Securities Exalter…
Read More
Japan AMED Establishes Program to Support Biopharmaceuticals
The Japanese government is aware of the challenges in securing funds for drug development within Japan’s biopharmaceutical startup ecosystem, especially…
Read More
